Aims and objectives. The aim of the study was to determine the rate of use of prenatal screening tests and the factors affecting the decision to have a prenatal screening test in pregnant women in Turkey. Background. Prenatal genetic screening as an optional service is commonly used to determine a level of risk for genetic conditions in the foetus. Design. A quantitative cross-sectional survey. Methods. Pregnant women (n = 274) who sought prenatal care from one hospital in Turkey were recruited and asked to complete questionnaires that were developed by the researchers. Descriptive and inferential statistics were used to analyse the data. Results. Almost half (44Á2) % of the women were primiparas, and the majority (97Á8%) were in the third trimester of pregnancy. Only 36Á1% of the women reported that they had prenatal screening by either the double test or triple test. Women had a low level of knowledge regarding prenatal screening: the mean knowledge score was 3Á43 AE 3Á21 of a possible score of 10. Having consanguineous marriage, a history of spontaneous abortion, a child with genetic disorder, multiparity or a longer marriage duration were positively correlated with accepting a prenatal screening test. Conclusions. This study has provided baseline data on the uptake and reasons for accepting or declining a prenatal screening in a cohort of Turkish women. There is evidence to suggest that more education is needed to improve knowledge and provide comprehensive nursing care to promote informed consent in this context. Relevance to clinical practice. Perinatal nurses are ideally situated to inform pregnant women about prenatal screening tests to improve access to healthcare services and to ensure informed decisions are made by pregnant women and their partners.
Introduction
Prenatal care (PNC) is crucial to improve infant health outcomes such as full-term birth and normal birthweight. The goals of PNC include risk assessment and reduction, health education and psychological support (Dolan et al. 2007 , Novick 2009 ). One of the objectives of the PNC is to identify women whose foetus is at risk for congenital and inherited conditions. Therefore, genetic assessment, screening and testing have been offered in the context of PNC for many years and in many countries (Dolan et al. 2007 , Skirton & Barr 2010 , Lewis 2011 , (2014) . Because prenatal genetic screening and testing are optional services, health professions need to provide women with the necessary education about screening and diagnostic tests to enable them to make informed decisions (Skirton & Barr 2010) .
Genetic testing is usually conducted on individuals when there is a known or high likelihood of risk, familial history or predisposition for a condition. Screening constitutes programmes of testing conducted on specific populations to identify risk of conditions where these are not known. Screening could be considered as a public health intervention (Andermann & Blancquaert 2010) . One type of prenatal screening includes maternal serum marker assessment and ultrasound examination to determine the risk level of the foetus for congenital abnormalities and chromosomal syndromes (Shaw et al. 2013 , Evans et al. 2015 . Commonly, this type of prenatal screening is offered in three ways: double screening, combined screening and triple screening. The double screening involves maternal serum of pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotropin (fbeta-hCG; Shaw et al. 2013 , Evans et al. 2015 . The combined screening includes the double screening with ultrasound examination for nuchal translucency thickness (NT) and absence and/or presence of the nasal bone (fbeta-hCG/PAPP-NT; Shaw et al. 2013 , Evans et al. 2015 . The triple screening involves maternal serum a-fetoprotein (AFP), unconjugated estriol and human chorionic gonadotropin (hCG; Dundar et al. 2011 , Shaw et al. 2013 , Evans et al. 2015 . There have been changes in the approach to prenatal screening and diagnosis recently. Besides the double and the triple test, there are other tests available such as the quad screening (AFP/HCG/estriol/Inhibin) as well as noninvasive prenatal screening with cell-free foetal DNA (Evans et al. 2015) . In Turkey, the Ministry of Health Antenatal Care Guide states that every women should be informed and offered the measurement of nuchal translucency thickness by ultrasonography and the combined test between 11-14 weeks of gestation, the maternal serum AFP and between 16-20 weeks of gestation, the triple/quad screening between 16-20 weeks of gestation (if the combined or the double test is not performed) and foetal anomaly scan at around 18 and 20 weeks of gestation during antenatal routine care. These tests are free for all women in Turkey (TPHI 2014).
Background
Over a fifty-year period, advances in prenatal screening for congenital abnormalities and chromosomal anomalies in particular have focused on obtaining higher sensitivity and lower false-positive rates through the use of biochemical, ultrasonography and most recently molecular markers (Skirton & Barr 2010 , Evans et al. 2015 . Benefits of detecting abnormalities during pregnancy include enabling clinicians and families to appropriately manage the pregnancy, plan for a high-risk delivery, and arrange for specialised postnatal medical care and support if necessary (Dolan et al. 2007 , Dundar et al. 2011 . Other benefits include providing reassurance regarding the health of the baby, planning for palliative care and engaging in early intervention for the foetus (Van den Berg et al. 2005 , Crombag et al. 2013 , English & Hessler 2013 . On the other hand, maternal serum and ultrasonography screening reveal risk indictors and do not confer direct diagnostic results. Therefore, false-negative and false-positive results are possible (Skirton & Barr 2010) . False-positive results may cause unnecessary anxiety and lead to unnecessary invasive procedures (Novick 2009 , Skirton & Barr 2010 . Prenatal screening can also cause parents to feel uncertain, fearful and lead to moral dilemmas surrounding treatment decisions (Van den Berg et al. 2005 , Crombag et al. 2013 , English & Hessler 2013 . A key decision couples face after their baby is diagnosed with a congenital or inherited disorder is whether to continue the pregnancy. Although termination may be an option (where it is legally available), it should not be forgotten that prenatal diagnosis of a foetus with a congenital or inherited disorder gives couples who decide to continue the pregnancy an opportunity to prepare for a baby with an abnormality (Van den Berg et al. 2005 , Skirton & Barr 2010 , Dundar et al. 2011 , Lewis 2011 , Crombag et al. 2013 , English & Hessler 2013 .
While foetal screening and testing allows parents to have more pregnancy management choices, there is evidence that in some countries, prenatal screening tests have become a part of routine antenatal care, and individuals do not know whether they have the right to refuse or accept (Skirton & Barr 2010 , Lewis 2011 , Shaw et al. 2013 . In a systematic review, Skirton and Barr (2007) established that when parents and healthcare professionals regarded prenatal screening as routine, informed decision-making does not take place. Lewis (2011) also found that many women signed the consent form to document their decision about genetic diagnostic tests but did not know why they were being tested or which test they were going to have. Women generally did not know the difference between screening and diagnostic tests, nor the implications of the results (Lewis 2011). In a seminal work, Appelbaum (2007) asserted that consent for testing requires that an individual understands information given by healthcare professionals is fully aware of the implications of the test and can communicate their decision to the professionals involved (Appelbaum 2007) . Therefore, it is necessary to give women the opportunity to ask questions that they may have, after receiving the required information related to prenatal screening tests.
Recently, research with pregnant women and their partners in making informed decision has been conducted to gain detailed insight and improve our understanding of women's complex needs with regard to prenatal screening tests (Dolan et al. 2007 , Skirton & Barr 2010 , Lewis 2011 , Gitsels-vander Wal et al. 2014a , Gitsels-vander Wal 2015 . However, knowledge is scarce about the factors effecting prenatal screening and diagnostic test use, and on prenatal screening tests among Turkish women. This is important to address because Turkish pregnant women cannot benefit from prenatal care if it is not tailored according to their preferences and needs. Moreover, it is important to enhance the nursing role to meet pregnant women's needs, because a nurse may play a crucial role in communicating geneticrelated implications to women and their families in the prenatal period, as part of the information that must be integrated for decision-making (Lewis 2011).
The aim of the study was to determine the rate of use of prenatal screening tests (the double and the triple test) and factors affecting the decision to have a prenatal screening test. To achieve this aim, two research questions were investigated: (1) What is the rate of use of prenatal screening tests among pregnant women in a Turkish health centre? (2) Which factors may influence their decisions to have prenatal screening test?
Methods

Study design
We used a cross-sectional survey design to investigate the use rate for prenatal screening tests and factors affecting decision-making for the uptake of prenatal screening in a large cohort of Turkish women.
Participants and procedures
This study was conducted in Turkey in an obstetrics outpatient clinic of a research and training hospital for four months during November 2014-February 2015. The relevant University Ethics Committee (2014Á134.IRB2Á036) approved the study, and the permission from the Public Hospital Association General Secretariat was obtained.
All pregnant women at more than 20 weeks of gestation who sought prenatal care from a single, approximately 800-bed, urban hospital during the study period were eligible for the study. Recruitment of the pregnant women took place on one day-two days a week when a research assistant (a senior nursing student) was able to attend the clinic. Upon registration, all pregnant women were informed about the study aims and methods in the waiting room by the research assistant. Approximately 320 women were approached, and 35 refused to participate in the study. Women who were willing to participate in the study were asked to individually fill out the two questionnaires. It took approximately 15-20 minutes to complete the questionnaires. A total of 285 women were recruited, and 11 women did not fill in the questionnaires completely. In total, 274 pregnant women were included in the study.
Questionnaire
To collect data, a 'Participant Information Form' and a 'Knowledge Assessment Form' were used. These questionnaires were developed based on literature review conducted by the researchers.
The Participant Information Form. consisted of 18 questions prepared to evaluate the demographic characteristics of the participants and their husbands/partners, and obstetric characteristics of the participants. We also asked whether the woman had a prenatal genetic screening (such as the double or the triple test), reasons for accepting or declining the test and any unmet educational needs in terms of prenatal genetic screening tests.
The Knowledge Assessment Form. comprised 10 true statements on the double test, triple test, test timing, possible results and further examination based on possible test results. To develop the form, a literature search was performed to find the most current information on prenatal screening options (Andermann & Blancquaert 2010 , Shaw et al. 2013 , TPHI 2014 , Evans et al. 2015 . To determine the general appropriateness and applicability for the form, the content validity was evaluated by three authors (KE, MS and AA), who are experts in obstetrical nursing. Women were asked to respond 'true', 'false' or 'do not know' to these statements. One point was given for each statement answered correctly; the total possible score was 10. The Cronbach's alpha statistic was used to measure internal consistency and was calculated as 0Á90, which shows a good level of reliability of the form (Bland & Altman 1997) .
Before the study was conducted, the questionnaires were pilot-tested with five pregnant women who were not included in the study. Minor changes such as spelling, rewording and adding new words to clarify the questions were made after this process.
Analyses
The SPSS for Windows (SPSS Inc., Chicago, IL, USA) software, version 21.0, was used to support the statistical analysis. The data were shown as frequency distributions in both counts and percentages. The chi-square and t-test were used for statistical comparison between groups. A p-value of <0Á05 was accepted as statistically significant. Table 1 shows the demographic characteristics of the 274 women who participated. None of the women reported that they or their husbands were personally affected with a genetic disorder, but six (2Á2%) reported that they had a child with genetic disorder (abnormal heart rhythm, Down syndrome and hormone deficiency). Ten women stated that they had a family history of genetic diseases.
Results
This was an open-ended question, and the respondents decided whether they thought a condition was genetic; the conditions reported were those such as diabetes mellitus, mental retardation, breast cancer, familial Mediterranean fever, epilepsy, depression and heart disease. The husbands of nine (2Á9%) women reported a family history of diabetes mellitus, heart disease and mental retardation. In 9Á9% of women (n = 27), the marriage was consanguineous.
Less than half (44Á2%) of the women were primiparas; the majority (97Á8%) were in the third trimester of pregnancy. Most women had neither a health problem during their current pregnancy (85Á8%), nor a chronic health problem before (92Á3%) the pregnancy. None had used reproductive technologies to become pregnant. Data related to the pregnancies are reported in Table 2 . Table 3 shows the women's histories of having noninvasive genetic screening tests (the triple or the double tests) of women during their current pregnancy. Only 36Á1% (n = 99) of the women reported they had prenatal screening by either the double test or triple test, and 21Á4% (n = 21) of participants at first considered declining the test due to different reasons, but then ultimately decided to get tested. Of the women who had a test and would have liked to SD: standard deviation, *3 are first-degree cousins, and the remainder are second-degree cousins. learn more about prenatal screening tests (n = 32, 32Á3%), seventeen (53%) wanted more information about ' the importance of the tests and why the tests should be performed' and seven (21Á8%) wanted more information about 'what they will do (or what they should do) if there is a bad result'. Also, 2Á5% of women (n = 7) had amniocentesis and 2Á2% (n = 6) of them did not have amniocentesis although the doctor had advised them to do so. Table 4 depicts women's level of knowledge regarding prenatal screening tests. There is a statistically significant relationship between the status of having a prenatal screening test and characteristics such as history of spontaneous abortion, parity, having a child with a genetic disorder, consanguineous marriage and duration of marriage (p < 0Á005). Also, having a history of spontaneous abortion, having consanguineous marriage, being multiparous and longer marriage duration were positively correlated with having a prenatal screening test (Table 5) .
Discussion
Recent national data show that in Turkey, not only are more women receiving antenatal care (ANC) (the proportion of women having four or more antenatal care visits is 89Á9%, compared with 55% in 2008), but also they appear to be more aware of the importance of early ANC visits than before (Hacettepe University Institute of Population Studies, 2014). All pregnant women in Turkey should be routinely offered prenatal screening as a part of their antenatal care, and the current practice in Turkey is to offer the double test between 11-13 weeks. Pregnant women presenting later on or declining first trimester screening are offered the triple or the quad test between 16-20 weeks of gestation (TPHI 2014) . In this study, 36Á1% of the pregnant women had prenatal screening by either the triple test 
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11. Mean of total score (0-10; min-max) 3Á43 AE 3Á21 or double test; these data are consistent with those derived from another Turkish study. Ergun (2007) found that 40Á8% of pregnant women had either (or both) the double test or triple test during pregnancy. Ergun (2007) also reported that 38Á8% of women were not aware of which test they had. In another Turkish study, Sahin and Gungor (2008) found that both perinatal screening and diagnostic tests are offered as a routine prenatal care in a hospital in Istanbul. They also reported that the main admission reason to the prenatal diagnosis unit was routine referral for first and second trimester ultrasound screening (Sahin & Gungor 2008) . Assuming that prenatal screening is seen as a routine part of antenatal care in Turkey, the rate of women who had screening in the current study is considered low, and therefore, it is thought that these results may be due to the participants' lack of awareness of tests they had during pregnancy. In the Netherlands, a recent nationwide study showed 23% of women had the combined test (Gitsels-vander Wal et al. 2014a) but findings among Muslim women in the same country indicated a somewhat lower rate of uptake for the combined test (mean rates 20%) (Gitselsvander Wal 2015b). Crombag et al. (2013) determined that in the Netherlands, uptake rates for Down syndrome screening are low compared with those in other Northern European countries (27% versus 61% in the United Kingdom and 90% in Denmark). These results may indicate that uptake varies widely from country to country, and this may be in part due to healthcare practices and regulations related to prenatal screening and diagnostic tests as well as cultural and religious attitudes about disability and termination of pregnancy. The goal of genetic counselling is to educate the woman and her partner about their specific levels of risk, risk reduction and reproductive options and to help couples who are at high risk of having a foetus with a congenital abnormality or genetic condition to make decisions about genetic testing (Lewis 2011 , Gregg et al. 2013 . Stefansdottir et al. (2010) found that 66% of pregnant women, in the first trimester of pregnancy, wanted all available information about prenatal screening and diagnosis. Gitsels -vander Wal et al. 2015) . In our study, many women believed that they had not had sufficient information about screening tests during their pregnancies; 32Á3% of pregnant women who had screening test would have liked to learn more about prenatal genetic screening tests. Therefore, it is unclear whether or not they made informed decisions. Lack of information is also supported by the knowledge scores. The mean knowledge score of women regarding prenatal screening tests was 3Á43 AE 3Á21 (of 10). Even given the time lapse since the tests were offered, this score is lower than would be considered acceptable for informed decision-making. In another Turkish study, 55Á5% of pregnant women who had either (or both) the double test or triple test defined the triple test as an 'intelligence test for their baby ' (Bilgin et al. 2010) , which also indicates a lack of understanding of the screening tests. In Iceland, Stefansdottir et al. (2010) found that the average knowledge level on prenatal screening and diagnostic tests was between 3Á3-4Á7 (of 8) depending on expectant mothers' educational level. Barr and Skirton (2013) reported that in the United Kingdom, many parents stated that they were not sufficiently informed and wanted individualised discussion with a healthcare professional about antenatal screening for Down syndrome. There may be some different reasons for pregnant women's lack of knowledge regarding prenatal screening tests in the study. For instance, Rowe et al. (2006) stated that healthcare professions are not well informed about tests and may lack the skills and knowledge necessary to convey information in a genetic context. On the other hand, time spent for informing women about prenatal screening test also may be an important factor in women's knowledge level. A study revealed that most obstetricians in Japan do not provide their patients with sufficient information about second trimester maternal serum screening. In the same study, it was also reported that the time spent with each patient explaining the screening process in more than half medical facilities was less than five minutes. This limited time may result in informing patients insufficiently (Okuyama et al. 2013) . Therefore, research focusing on the reasons behind pregnant women's lack of knowledge is essential to adjust the health care provided accordingly. In our study, educational level and knowledge level of women regarding prenatal tests were not correlated with women's decision to have a prenatal screening test. Likewise, in a study, Stefansdottir et al. reported (2010) that there was no effect of knowledge level regarding prenatal screening and diagnosis. Having a child with genetic condition, having a history of spontaneous abortion, being multiparous and longer marriage duration were positively correlated with having a prenatal screening test in the current study. Similarly, the Icelandic researchers (Stefansdottir et al. 2010) indicated that personal experience of birth defects was likely to influence the acceptance of screening and this was also the case in our cohort. Even though religion was not investigated in the current study, its affect on prenatal screening has been reported in Israel. Sher et al. (2003) reported 60Á9% and 80Á4% of Israeli Jewish religious and secular women accepted the triple test with the high rate of uptake in the secular group. The main reason reported by Israeli Jewish women for not performing amniocentesis or the triple test was for religious or moral grounds (Sher et al. 2003) . In addition, Gitsels vanderWal et al. (2014b) stated that Islamic faith played a role in decision-making on having the combined test in the study conducted in Muslim Turkish origin immigrants living in the Netherlands (Gitsels-van der Wal et al. 2014b). As Turkey is a country where the Muslim faith is dominant, this may be a factor effecting decisions about having screening or diagnostic tests and could account for lower rates of uptake of screening in our study. However, Crombag et al. (2013) concluded that decision-making on uptake of a screening test for Down syndrome is a complex process that takes into consideration many different and interacting factors rather than a simple yes-no decision. Perception towards Down syndrome, perceived guidance of healthcare professionals and thoughts on abortion may play a role in the decision whether to take the test or not (Crombag et al. 2013) . Therefore, further qualitative studies are needed to explore and improve our understanding of reasons and rationales for acceptability of prenatal screening and diagnostic testing in Turkish society.
While Turkish nurses working in obstetric clinics are called prenatal nurses, there is no special training or certification for becoming a prenatal nurse with the exception of continuing nursing education. According to the Turkish nursing regulations (Republic of Turkey Ministry of Health's website, http://saglik.gov.tr/EN/belge/1-12606/hemsirelikyonetmeliginde-degisiklik-yapilmasina-dair-,-.html), they are responsible for providing counselling for families at risk of genetic conditions as well as providing antenatal and postnatal care to women. Healthcare professionals, especially perinatal nurses who are often in contact with pregnant woman, have a role to provide information regarding prenatal screening tests, to ensure each individual has been informed, and to identify individuals who are at high risk and might benefit from genetic counselling. Rowe et al. (2006) reported that the participation rate in screening is higher in pregnant women who have made an informed decision then among those who did not. To ensure informed decision-making, time for consideration by both partners is needed. Therefore, ideally, couples should be aware of the opportunity to have a screening test and time to discuss this before the decision has to be made.
Limitations
We were able to recruit a relatively large cohort of Turkish women; however, they were recruited in one centre. Therefore, the results of the study are not generalisable. Further qualitative research is recommended to assess in detail the motives for having or not having screening test. The questionnaires used in this study were developed by the researchers, as there is no validated questionnaire assessing knowledge level of women related to prenatal screening.
Relevance to clinical practice
The study provides better understanding of acceptance or nonacceptance of prenatal screening and needs of pregnant women about prenatal screening in Turkey. In prenatal screening, knowing pregnant women's opinions and knowledge level can inform healthcare professionals regarding women's educational needs in this respect. Healthcare professionals should provide information about screening tests to all pregnant women with more attention to pregnant women who are at risk for any genetic condition. Perinatal nurses as a first contact point for pregnant women are ideally situated to inform pregnant women about prenatal screening tests to improve access to healthcare services and to ensure informed decisions are made by pregnant women and their partners.
Conclusion
This study contributes to baseline data on the uptake and reasons for acceptance or nonacceptance of screening in a cohort of Turkish women. Women who are multiparous and have a child with genetic condition, history of spontaneous abortion and longer marriage are most likely to have prenatal screening test. It is evident that more information and education is needed to promote informed decisionmaking and consent and to provide adequate prenatal care as part of nursing care in this context.
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